 | • レポートコード：MRC2-11QY01795 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は静脈内（IV）鉄剤のグローバル市場について調査・分析したレポートです。種類別（低分子量鉄デキストラン、グルコン酸第二鉄、スクロース鉄、マルトース第二鉄）市場規模、用途別（病院、外来外科センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別静脈内（IV）鉄剤の競争状況、市場シェア ・世界の静脈内（IV）鉄剤市場：種類別市場規模 2015年-2020年（低分子量鉄デキストラン、グルコン酸第二鉄、スクロース鉄、マルトース第二鉄） ・世界の静脈内（IV）鉄剤市場：種類別市場規模予測 2021年-2026年（低分子量鉄デキストラン、グルコン酸第二鉄、スクロース鉄、マルトース第二鉄） ・世界の静脈内（IV）鉄剤市場：用途別市場規模 2015年-2020年（病院、外来外科センター、診断センター） ・世界の静脈内（IV）鉄剤市場：用途別市場規模予測 2021年-2026年（病院、外来外科センター、診断センター） ・北米の静脈内（IV）鉄剤市場分析：米国、カナダ ・ヨーロッパの静脈内（IV）鉄剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの静脈内（IV）鉄剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の静脈内（IV）鉄剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの静脈内（IV）鉄剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、AMAG Pharmaceuticals、Galenica、Actavis、American Regent、Sanofi、Luitpold Pharmaceuticals、Fresenius Medical Care、Pharmacosmos、Vifor Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal absorption, and non-compliance.
Major drivers of the IV iron drugs market are increase in incidence of iron deficiency, rise in chronic kidney disease patients undergoing dialysis, and surging diabetic population. Increase in iron deficiency anemia in gynecology, oncology, and gastroenterology, noncompliance of oral therapy, and accurate, easy, and convenient access to IV iron dosages drive demand for intravenous iron drugs. However, complex approval process, stringent regulations, drug side effects, nutraceutical alternatives to prevent iron deficiency, and product price are likely to act as major restraints of the IV iron drugs market.
Market Analysis and Insights: Global Intraveno(IV) Iron Drugs Market
The global Intraveno(IV) Iron Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Intraveno(IV) Iron Drugs Scope and Market Size
Intraveno(IV) Iron Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intraveno(IV) Iron Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Intraveno(IV) Iron Drugs market is segmented into
Low Molecular Weight Iron Dextran
Ferric Gluconate
Iron Sucrose
Ferric Carboxyl Maltose
Segment by Application, the Intraveno(IV) Iron Drugs market is segmented into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Regional and Country-level Analysis
The Intraveno(IV) Iron Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Intraveno(IV) Iron Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Intraveno(IV) Iron Drugs Market Share Analysis
Intraveno(IV) Iron Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Intraveno(IV) Iron Drugs business, the date to enter into the Intraveno(IV) Iron Drugs market, Intraveno(IV) Iron Drugs product introduction, recent developments, etc.
The major vendors covered:
Allergan
AMAG Pharmaceuticals
Galenica
Actavis
American Regent
Sanofi
Luitpold Pharmaceuticals
Fresenius Medical Care
Pharmacosmos
Vifor Pharma
1 Study Coverage
1.1 Intraveno(IV) Iron Drugs Product Introduction
1.2 Market Segments
1.3 Key Intraveno(IV) Iron Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Intraveno(IV) Iron Drugs Market Size Growth Rate by Type
1.4.2 Low Molecular Weight Iron Dextran
1.4.3 Ferric Gluconate
1.4.4 Iron Sucrose
1.4.5 Ferric Carboxyl Maltose
1.5 Market by Application
1.5.1 Global Intraveno(IV) Iron Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Intraveno(IV) Iron Drugs Market Size, Estimates and Forecasts
2.1.1 Global Intraveno(IV) Iron Drugs Revenue 2015-2026
2.1.2 Global Intraveno(IV) Iron Drugs Sales 2015-2026
2.2 Global Intraveno(IV) Iron Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Intraveno(IV) Iron Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Intraveno(IV) Iron Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Intraveno(IV) Iron Drugs Competitor Landscape by Players
3.1 Intraveno(IV) Iron Drugs Sales by Manufacturers
3.1.1 Intraveno(IV) Iron Drugs Sales by Manufacturers (2015-2020)
3.1.2 Intraveno(IV) Iron Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Intraveno(IV) Iron Drugs Revenue by Manufacturers
3.2.1 Intraveno(IV) Iron Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Intraveno(IV) Iron Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Intraveno(IV) Iron Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Intraveno(IV) Iron Drugs Revenue in 2019
3.2.5 Global Intraveno(IV) Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Intraveno(IV) Iron Drugs Price by Manufacturers
3.4 Intraveno(IV) Iron Drugs Manufacturing Base Distribution, Product Types
3.4.1 Intraveno(IV) Iron Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intraveno(IV) Iron Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Intraveno(IV) Iron Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Intraveno(IV) Iron Drugs Market Size by Type (2015-2020)
4.1.1 Global Intraveno(IV) Iron Drugs Sales by Type (2015-2020)
4.1.2 Global Intraveno(IV) Iron Drugs Revenue by Type (2015-2020)
4.1.3 Intraveno(IV) Iron Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Intraveno(IV) Iron Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Intraveno(IV) Iron Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Intraveno(IV) Iron Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Intraveno(IV) Iron Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Intraveno(IV) Iron Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Intraveno(IV) Iron Drugs Market Size by Application (2015-2020)
5.1.1 Global Intraveno(IV) Iron Drugs Sales by Application (2015-2020)
5.1.2 Global Intraveno(IV) Iron Drugs Revenue by Application (2015-2020)
5.1.3 Intraveno(IV) Iron Drugs Price by Application (2015-2020)
5.2 Intraveno(IV) Iron Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Intraveno(IV) Iron Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Intraveno(IV) Iron Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Intraveno(IV) Iron Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Intraveno(IV) Iron Drugs by Country
6.1.1 North America Intraveno(IV) Iron Drugs Sales by Country
6.1.2 North America Intraveno(IV) Iron Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Intraveno(IV) Iron Drugs Market Facts & Figures by Type
6.3 North America Intraveno(IV) Iron Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Intraveno(IV) Iron Drugs by Country
7.1.1 Europe Intraveno(IV) Iron Drugs Sales by Country
7.1.2 Europe Intraveno(IV) Iron Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intraveno(IV) Iron Drugs Market Facts & Figures by Type
7.3 Europe Intraveno(IV) Iron Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Intraveno(IV) Iron Drugs by Region
8.1.1 Asia Pacific Intraveno(IV) Iron Drugs Sales by Region
8.1.2 Asia Pacific Intraveno(IV) Iron Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Intraveno(IV) Iron Drugs Market Facts & Figures by Type
8.3 Asia Pacific Intraveno(IV) Iron Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Intraveno(IV) Iron Drugs by Country
9.1.1 Latin America Intraveno(IV) Iron Drugs Sales by Country
9.1.2 Latin America Intraveno(IV) Iron Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Intraveno(IV) Iron Drugs Market Facts & Figures by Type
9.3 Central & South America Intraveno(IV) Iron Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Intraveno(IV) Iron Drugs by Country
10.1.1 Middle East and Africa Intraveno(IV) Iron Drugs Sales by Country
10.1.2 Middle East and Africa Intraveno(IV) Iron Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Intraveno(IV) Iron Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Intraveno(IV) Iron Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Intraveno(IV) Iron Drugs Products Offered
11.1.5 Allergan Related Developments
11.2 AMAG Pharmaceuticals
11.2.1 AMAG Pharmaceuticals Corporation Information
11.2.2 AMAG Pharmaceuticals Description and Business Overview
11.2.3 AMAG Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AMAG Pharmaceuticals Intraveno(IV) Iron Drugs Products Offered
11.2.5 AMAG Pharmaceuticals Related Developments
11.3 Galenica
11.3.1 Galenica Corporation Information
11.3.2 Galenica Description and Business Overview
11.3.3 Galenica Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Galenica Intraveno(IV) Iron Drugs Products Offered
11.3.5 Galenica Related Developments
11.4 Actavis
11.4.1 Actavis Corporation Information
11.4.2 Actavis Description and Business Overview
11.4.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Actavis Intraveno(IV) Iron Drugs Products Offered
11.4.5 Actavis Related Developments
11.5 American Regent
11.5.1 American Regent Corporation Information
11.5.2 American Regent Description and Business Overview
11.5.3 American Regent Sales, Revenue and Gross Margin (2015-2020)
11.5.4 American Regent Intraveno(IV) Iron Drugs Products Offered
11.5.5 American Regent Related Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description and Business Overview
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Intraveno(IV) Iron Drugs Products Offered
11.6.5 Sanofi Related Developments
11.7 Luitpold Pharmaceuticals
11.7.1 Luitpold Pharmaceuticals Corporation Information
11.7.2 Luitpold Pharmaceuticals Description and Business Overview
11.7.3 Luitpold Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Luitpold Pharmaceuticals Intraveno(IV) Iron Drugs Products Offered
11.7.5 Luitpold Pharmaceuticals Related Developments
11.8 Fresenius Medical Care
11.8.1 Fresenius Medical Care Corporation Information
11.8.2 Fresenius Medical Care Description and Business Overview
11.8.3 Fresenius Medical Care Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Fresenius Medical Care Intraveno(IV) Iron Drugs Products Offered
11.8.5 Fresenius Medical Care Related Developments
11.9 Pharmacosmos
11.9.1 Pharmacosmos Corporation Information
11.9.2 Pharmacosmos Description and Business Overview
11.9.3 Pharmacosmos Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pharmacosmos Intraveno(IV) Iron Drugs Products Offered
11.9.5 Pharmacosmos Related Developments
11.10 Vifor Pharma
11.10.1 Vifor Pharma Corporation Information
11.10.2 Vifor Pharma Description and Business Overview
11.10.3 Vifor Pharma Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Vifor Pharma Intraveno(IV) Iron Drugs Products Offered
11.10.5 Vifor Pharma Related Developments
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Intraveno(IV) Iron Drugs Products Offered
11.1.5 Allergan Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Intraveno(IV) Iron Drugs Market Estimates and Projections by Region
12.1.1 Global Intraveno(IV) Iron Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Intraveno(IV) Iron Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Intraveno(IV) Iron Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Intraveno(IV) Iron Drugs Sales Forecast (2021-2026)
12.2.2 North America: Intraveno(IV) Iron Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Intraveno(IV) Iron Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Intraveno(IV) Iron Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Intraveno(IV) Iron Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Intraveno(IV) Iron Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Intraveno(IV) Iron Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Intraveno(IV) Iron Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Intraveno(IV) Iron Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Intraveno(IV) Iron Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Intraveno(IV) Iron Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Intraveno(IV) Iron Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Intraveno(IV) Iron Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Intraveno(IV) Iron Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Intraveno(IV) Iron Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Intraveno(IV) Iron Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Intraveno(IV) Iron Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Intraveno(IV) Iron Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Intraveno(IV) Iron Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Intraveno(IV) Iron Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intraveno(IV) Iron Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Intraveno(IV) Iron Drugs Market Segments
Table 2. Ranking of Global Top Intraveno(IV) Iron Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Intraveno(IV) Iron Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Low Molecular Weight Iron Dextran
Table 5. Major Manufacturers of Ferric Gluconate
Table 6. Major Manufacturers of Iron Sucrose
Table 7. Major Manufacturers of Ferric Carboxyl Maltose
Table 8. Global Intraveno(IV) Iron Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Intraveno(IV) Iron Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Intraveno(IV) Iron Drugs Sales by Regions 2015-2020 (K MT)
Table 11. Global Intraveno(IV) Iron Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Intraveno(IV) Iron Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Intraveno(IV) Iron Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Intraveno(IV) Iron Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Intraveno(IV) Iron Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Intraveno(IV) Iron Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intraveno(IV) Iron Drugs as of 2019)
Table 17. Intraveno(IV) Iron Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Intraveno(IV) Iron Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Intraveno(IV) Iron Drugs Price (2015-2020) (USD/MT)
Table 20. Intraveno(IV) Iron Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Intraveno(IV) Iron Drugs Product Type
Table 22. Date of International Manufacturers Enter into Intraveno(IV) Iron Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Intraveno(IV) Iron Drugs Sales by Type (2015-2020) (K MT)
Table 25. Global Intraveno(IV) Iron Drugs Sales Share by Type (2015-2020)
Table 26. Global Intraveno(IV) Iron Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Intraveno(IV) Iron Drugs Revenue Share by Type (2015-2020)
Table 28. Intraveno(IV) Iron Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Intraveno(IV) Iron Drugs Sales by Application (2015-2020) (K MT)
Table 30. Global Intraveno(IV) Iron Drugs Sales Share by Application (2015-2020)
Table 31. North America Intraveno(IV) Iron Drugs Sales by Country (2015-2020) (K MT)
Table 32. North America Intraveno(IV) Iron Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Intraveno(IV) Iron Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Intraveno(IV) Iron Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Intraveno(IV) Iron Drugs Sales by Type (2015-2020) (K MT)
Table 36. North America Intraveno(IV) Iron Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Intraveno(IV) Iron Drugs Sales by Application (2015-2020) (K MT)
Table 38. North America Intraveno(IV) Iron Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Intraveno(IV) Iron Drugs Sales by Country (2015-2020) (K MT)
Table 40. Europe Intraveno(IV) Iron Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Intraveno(IV) Iron Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Intraveno(IV) Iron Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Intraveno(IV) Iron Drugs Sales by Type (2015-2020) (K MT)
Table 44. Europe Intraveno(IV) Iron Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Intraveno(IV) Iron Drugs Sales by Application (2015-2020) (K MT)
Table 46. Europe Intraveno(IV) Iron Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Intraveno(IV) Iron Drugs Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Intraveno(IV) Iron Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Intraveno(IV) Iron Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Intraveno(IV) Iron Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Intraveno(IV) Iron Drugs Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Intraveno(IV) Iron Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Intraveno(IV) Iron Drugs Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Intraveno(IV) Iron Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Intraveno(IV) Iron Drugs Sales by Country (2015-2020) (K MT)
Table 56. Latin America Intraveno(IV) Iron Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Intraveno(IV) Iron Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Intraveno(IV) Iron Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Intraveno(IV) Iron Drugs Sales by Type (2015-2020) (K MT)
Table 60. Latin America Intraveno(IV) Iron Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Intraveno(IV) Iron Drugs Sales by Application (2015-2020) (K MT)
Table 62. Latin America Intraveno(IV) Iron Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Intraveno(IV) Iron Drugs Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Intraveno(IV) Iron Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Intraveno(IV) Iron Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Intraveno(IV) Iron Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Intraveno(IV) Iron Drugs Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Intraveno(IV) Iron Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Intraveno(IV) Iron Drugs Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Intraveno(IV) Iron Drugs Sales Market Share by Application (2015-2020)
Table 71. Allergan Corporation Information
Table 72. Allergan Description and Major Businesses
Table 73. Allergan Intraveno(IV) Iron Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Allergan Product
Table 75. Allergan Recent Development
Table 76. AMAG Pharmaceuticals Corporation Information
Table 77. AMAG Pharmaceuticals Description and Major Businesses
Table 78. AMAG Pharmaceuticals Intraveno(IV) Iron Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. AMAG Pharmaceuticals Product
Table 80. AMAG Pharmaceuticals Recent Development
Table 81. Galenica Corporation Information
Table 82. Galenica Description and Major Businesses
Table 83. Galenica Intraveno(IV) Iron Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Galenica Product
Table 85. Galenica Recent Development
Table 86. Actavis Corporation Information
Table 87. Actavis Description and Major Businesses
Table 88. Actavis Intraveno(IV) Iron Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Actavis Product
Table 90. Actavis Recent Development
Table 91. American Regent Corporation Information
Table 92. American Regent Description and Major Businesses
Table 93. American Regent Intraveno(IV) Iron Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. American Regent Product
Table 95. American Regent Recent Development
Table 96. Sanofi Corporation Information
Table 97. Sanofi Description and Major Businesses
Table 98. Sanofi Intraveno(IV) Iron Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Sanofi Product
Table 100. Sanofi Recent Development
Table 101. Luitpold Pharmaceuticals Corporation Information
Table 102. Luitpold Pharmaceuticals Description and Major Businesses
Table 103. Luitpold Pharmaceuticals Intraveno(IV) Iron Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Luitpold Pharmaceuticals Product
Table 105. Luitpold Pharmaceuticals Recent Development
Table 106. Fresenius Medical Care Corporation Information
Table 107. Fresenius Medical Care Description and Major Businesses
Table 108. Fresenius Medical Care Intraveno(IV) Iron Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Fresenius Medical Care Product
Table 110. Fresenius Medical Care Recent Development
Table 111. Pharmacosmos Corporation Information
Table 112. Pharmacosmos Description and Major Businesses
Table 113. Pharmacosmos Intraveno(IV) Iron Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Pharmacosmos Product
Table 115. Pharmacosmos Recent Development
Table 116. Vifor Pharma Corporation Information
Table 117. Vifor Pharma Description and Major Businesses
Table 118. Vifor Pharma Intraveno(IV) Iron Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Vifor Pharma Product
Table 120. Vifor Pharma Recent Development
Table 121. Global Intraveno(IV) Iron Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 122. Global Intraveno(IV) Iron Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 123. Global Intraveno(IV) Iron Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 124. Global Intraveno(IV) Iron Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 125. North America: Intraveno(IV) Iron Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 126. North America: Intraveno(IV) Iron Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Europe: Intraveno(IV) Iron Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 128. Europe: Intraveno(IV) Iron Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Asia Pacific: Intraveno(IV) Iron Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 130. Asia Pacific: Intraveno(IV) Iron Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 131. Latin America: Intraveno(IV) Iron Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 132. Latin America: Intraveno(IV) Iron Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Middle East and Africa: Intraveno(IV) Iron Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 134. Middle East and Africa: Intraveno(IV) Iron Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 136. Key Challenges
Table 137. Market Risks
Table 138. Main Points Interviewed from Key Intraveno(IV) Iron Drugs Players
Table 139. Intraveno(IV) Iron Drugs Customers List
Table 140. Intraveno(IV) Iron Drugs Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Intraveno(IV) Iron Drugs Product Picture
Figure 2. Global Intraveno(IV) Iron Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Low Molecular Weight Iron Dextran Product Picture
Figure 4. Ferric Gluconate Product Picture
Figure 5. Iron Sucrose Product Picture
Figure 6. Ferric Carboxyl Maltose Product Picture
Figure 7. Global Intraveno(IV) Iron Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Ambulatory Surgical Centers
Figure 10. Diagnostic Centers
Figure 11. Intraveno(IV) Iron Drugs Report Years Considered
Figure 12. Global Intraveno(IV) Iron Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Intraveno(IV) Iron Drugs Sales 2015-2026 (K MT)
Figure 14. Global Intraveno(IV) Iron Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Intraveno(IV) Iron Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Intraveno(IV) Iron Drugs Sales Market Share by Region in 2019
Figure 17. Global Intraveno(IV) Iron Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Intraveno(IV) Iron Drugs Revenue Market Share by Region in 2019
Figure 19. Global Intraveno(IV) Iron Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Intraveno(IV) Iron Drugs Revenue in 2019
Figure 21. Intraveno(IV) Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Intraveno(IV) Iron Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Intraveno(IV) Iron Drugs Sales Market Share by Type in 2019
Figure 24. Global Intraveno(IV) Iron Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Intraveno(IV) Iron Drugs Revenue Market Share by Type in 2019
Figure 26. Global Intraveno(IV) Iron Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Intraveno(IV) Iron Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Intraveno(IV) Iron Drugs Sales Market Share by Application in 2019
Figure 29. Global Intraveno(IV) Iron Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Intraveno(IV) Iron Drugs Revenue Market Share by Application in 2019
Figure 31. North America Intraveno(IV) Iron Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Intraveno(IV) Iron Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Intraveno(IV) Iron Drugs Sales Market Share by Country in 2019
Figure 34. North America Intraveno(IV) Iron Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Intraveno(IV) Iron Drugs Market Share by Type in 2019
Figure 40. North America Intraveno(IV) Iron Drugs Market Share by Application in 2019
Figure 41. Europe Intraveno(IV) Iron Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Intraveno(IV) Iron Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Intraveno(IV) Iron Drugs Sales Market Share by Country in 2019
Figure 44. Europe Intraveno(IV) Iron Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Intraveno(IV) Iron Drugs Market Share by Type in 2019
Figure 56. Europe Intraveno(IV) Iron Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Intraveno(IV) Iron Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Intraveno(IV) Iron Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Intraveno(IV) Iron Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Intraveno(IV) Iron Drugs Revenue Market Share by Region in 2019
Figure 61. China Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Intraveno(IV) Iron Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Intraveno(IV) Iron Drugs Market Share by Application in 2019
Figure 85. Latin America Intraveno(IV) Iron Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Intraveno(IV) Iron Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Intraveno(IV) Iron Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Intraveno(IV) Iron Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Intraveno(IV) Iron Drugs Market Share by Type in 2019
Figure 96. Latin America Intraveno(IV) Iron Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Intraveno(IV) Iron Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Intraveno(IV) Iron Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Intraveno(IV) Iron Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Intraveno(IV) Iron Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Intraveno(IV) Iron Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Intraveno(IV) Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Intraveno(IV) Iron Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Intraveno(IV) Iron Drugs Market Share by Application in 2019
Figure 109. North America Intraveno(IV) Iron Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Intraveno(IV) Iron Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Intraveno(IV) Iron Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Intraveno(IV) Iron Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Intraveno(IV) Iron Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Intraveno(IV) Iron Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Intraveno(IV) Iron Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Intraveno(IV) Iron Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Intraveno(IV) Iron Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Intraveno(IV) Iron Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
鉄剤の世界市場（～2026年） Iron is required to transport oxygen through haemoglobin in red blood cells (RBCs) and oxidize cells through cytochrome. Iron deficiency is a common cause of anaemia. Iron drugs are used to treat people with iron deficiency. In terms of geographic regions, the North Americas accounted for the major …- 静脈内鉄薬の世界市場（～2026年） Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of …
- 電気アイロンの世界市場（～2026年） Electric iron is a tool for leveling clothes and fabrics, and the power is generally between 300-1000W. Its type can be divided into: ordinary type, temperature control type, steam spray type and so on. Ordinary irons have a simple structure, they are inexpensive, and are easy to manufacture and mai…
- 亜鉛鉄コーティング剤の世界市場（～2026年） Market Analysis and Insights: Global Zinc Iron Coatings Market The global Zinc Iron Coatings market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Zinc Iron Coatings Scope and Market Size Zinc Iron Coatings market is segment…
- 鋳鉄・鋳鉄鋳物の世界市場（～2026年） Market Analysis and Insights: Global Cast Iron & Cast Iron Castings Market The global Cast Iron & Cast Iron Castings market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cast Iron & Cast Iron Castings Scope and Market Size …